6533b870fe1ef96bd12cfe08

RESEARCH PRODUCT

An in vitro and in vivo study of peptide-functionalized nanoparticles for brain targeting: The importance of selective blood-brain barrier uptake

G.m.j.p.c. CouéRonald E. UngerLeto TzivelekaFrank SinnerHarry W.m. SteinbuschEleonore FröhlichKrystyna AlbrechtChristoph SchmitzMaria Sánchez-purràPilar Martinez-martinezSmriti SinghJürgen GrollEwoud C. Van WindenChristian FreeseChristian GrandfilsSalvador BorrósBerta AlbaigesHans Georg FrankC. James KirkpatrickAndy J.g. PötgensKarin E. PicklGerard H. BodeJohan F.j. EngbersenZili SideratouMartin Möller

subject

Male0301 basic medicinePharmaceutical ScienceMedicine (miscellaneous)LIPOSOMES02 engineering and technologyPharmacologyDrug Delivery SystemsTissue DistributionGeneral Materials ScienceDENDRIMERSDRUG-DELIVERYCytotoxicityDrug CarriersLiposomeBrain021001 nanoscience & nanotechnologyMETHOTREXATEmedicine.anatomical_structureBlood-Brain BarrierDrug deliveryMolecular MedicineNanomedicine0210 nano-technologyMaterials scienceBiomedical EngineeringBioengineeringBlood–brain barrierMEDIATED TRANSPORTCell Line03 medical and health sciencesIn vivomedicineAnimalsHumansAmino Acid SequenceRats WistarDENDRITIC POLYMERSTargetingSENSITIVE HYDROGELSBiological TransportIn vitron/a OA procedure030104 developmental biologyNANOGELSNanoparticles for drug delivery to the brain80-COATED POLYBUTYLCYANOACRYLATE NANOPARTICLESCELLSNanoparticlesPeptides

description

Targeted delivery of drugs across endothelial barriers remains a formidable challenge, especially in the case of the brain, where the blood-brain barrier severely limits entry of drugs into the central nervous system. Nanoparticle-mediated transport of peptide/protein-based drugs across endothelial barriers shows great potential as a therapeutic strategy in a wide variety of diseases. Functionalizing nanoparticles with peptides allows for more efficient targeting to specific organs. We have evaluated the hemocompatibilty, cytotoxicity, endothelial uptake, efficacy of delivery and safety of liposome, hyperbranched polyester, poly(glycidol) and acrylamide-based nanoparticles functionalized with peptides targeting brain endothelial receptors, in vitro and in vivo. We used an ELISA-based method for the detection of nanoparticles in biological fluids, investigating the blood clearance rate and in vivo biodistribution of labeled nanoparticles in the brain after intravenous injection in Wistar rats. Herein, we provide a detailed report of in vitro and in vivo observations. (C) 2016 Elsevier Inc. All rights reserved.

10.1016/j.nano.2016.11.009https://cris.maastrichtuniversity.nl/en/publications/0657ddb6-7c57-4a6c-ae0b-f821ccdff6bc